Patient-derived micro-organospheres enable clinical precision oncology.

Saved in:
Bibliographic Details
Title: Patient-derived micro-organospheres enable clinical precision oncology.
Authors: Ding S; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Xilis, Inc., Durham, NC 27713, USA., Hsu C; College of Arts and Sciences, University of Chapel Hill, Chapel Hill, NC 27599, USA., Wang Z; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Xilis, Inc., Durham, NC 27713, USA., Natesh NR; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Millen R; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Negrete M; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Giroux N; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Rivera GO; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Dohlman A; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Bose S; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Rotstein T; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Spiller K; Xilis, Inc., Durham, NC 27713, USA., Yeung A; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Sun Z; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Jiang C; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA., Xi R; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Wilkin B; Xilis, Inc., Durham, NC 27713, USA., Randon PM; National Institute of Environmental Health Sciences (NIEHS), Durham, NC 27709, USA., Williamson I; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Nelson DA; Xilis, Inc., Durham, NC 27713, USA., Delubac D; Xilis, Inc., Durham, NC 27713, USA., Oh S; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Rupprecht G; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Isaacs J; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Jia J; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Chen C; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA., Shen JP; Department of Gastrointestinal Medical Oncology, MD Anderson, Houston, TX 77030, USA., Kopetz S; Department of Gastrointestinal Medical Oncology, MD Anderson, Houston, TX 77030, USA., McCall S; Department of Pathology, Duke University, Durham, NC 27708, USA., Smith A; Xilis, Inc., Durham, NC 27713, USA., Gjorevski N; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel 4058, Switzerland., Walz AC; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel 4058, Switzerland., Antonia S; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Marrer-Berger E; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel 4058, Switzerland., Clevers H; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel 4058, Switzerland. Electronic address: h.clevers@hubrecht.eu., Hsu D; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA. Electronic address: shiaowen.hsu@duke.edu., Shen X; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA. Electronic address: xiling.shen@terasaki.org.
Source: Cell stem cell [Cell Stem Cell] 2022 Jun 02; Vol. 29 (6), pp. 905-917.e6. Date of Electronic Publication: 2022 May 03.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9777 (Electronic) Linking ISSN: 18759777 NLM ISO Abbreviation: Cell Stem Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1875-9777
DOI:10.1016/j.stem.2022.04.006